Month: February 2020

  • 12th Ludwig Boltzmann Forum Tokyo 2020

    12th Ludwig Boltzmann Forum Tokyo 2020

    Energy. Entropy. Leadership.

    Gerhard Fasol, Chair and Producer.

    12th Ludwig Boltzmann Forum 2020, Thursday 20 February 2020 at the Embassy of Austria, Tokyo.

    12th Ludwig Boltzmann Forum Tokyo 2020
    12th Ludwig Boltzmann Forum Tokyo 2020
    12th Ludwig Boltzmann Forum Tokyo 2020
    12th Ludwig Boltzmann Forum Tokyo 2020. Speakers: Masaki Ogata (Vice-Chairman JR-East Railway Company), Hiromitsu Nakauchi (Professor at Stanford University and Tokyo University), Gerhard Fasol (Creator and Chair, Ludwig Boltzmann Forum), Masashi Yanagisawa (Professor Tsukuba University and Director of the International Institute for Integrative Sleep Medicine), Satoshi Nagata (NTT DOCOMO Inc., 3GPP TSG-RAN Vice-Chairman) (from left to right)

    Program

    click on links below to read summaries of keynote talks and see photographs

    12th Ludwig Boltzmann Forum Tokyo 2020
    12th Ludwig Boltzmann Forum Tokyo 2020. Welcome by the Ambassador of Austria, Hubert Heiss.
    Gerhard Fasol: Today's agenda , entropy, information, leadership, Ludwig Boltzmann and Japan's economic growth
    Gerhard Fasol: Today’s agenda , entropy, information, leadership, Ludwig Boltzmann and Japan’s economic growth
    12th Ludwig Boltzmann Forum Tokyo 2020
    12th Ludwig Boltzmann Forum Tokyo 2020. Masaki Ogata, East Japan Railway Company, Board Director and Vice-Chairman, Executive Vice President of Technology & Overseas Related Affairs
    12th Ludwig Boltzmann Forum Tokyo 2020
    12th Ludwig Boltzmann Forum Tokyo 2020 Masaki Ogata, East Japan Railway Company, Board Director and Vice-Chairman, Executive Vice President of Technology and Overseas Related Affairs
    12th Ludwig Boltzmann Forum Tokyo 2020
    12th Ludwig Boltzmann Forum Tokyo 2020. Masaki Ogata, East Japan Railway Company, Board Director and Vice-Chairman, Executive Vice President of Technology & Overseas Related Affairs
    12th Ludwig Boltzmann Forum Tokyo 2020
    12th Ludwig Boltzmann Forum Tokyo 2020. Masashi Yanagisawa (Professor Tsukuba University and Director of the International Institute for Integrative Sleep Medicine)
    12th Ludwig Boltzmann Forum Tokyo 2020
    12th Ludwig Boltzmann Forum Tokyo 2020. Masashi Yanagisawa (Professor Tsukuba University and Director of the International Institute for Integrative Sleep Medicine)
    12th Ludwig Boltzmann Forum Tokyo 2020
    12th Ludwig Boltzmann Forum Tokyo 2020
    12th Ludwig Boltzmann Forum Tokyo 2020
    12th Ludwig Boltzmann Forum Tokyo 2020. Masashi Yanagisawa, International Institute for Integrative Sleep Medicine (WPI-IIIS), Director, and University of Tsukuba, Professor
    12th Ludwig Boltzmann Forum Tokyo 2020
    12th Ludwig Boltzmann Forum Tokyo 2020. Masashi Yanagisawa (Professor Tsukuba University and Director of the International Institute for Integrative Sleep Medicine)
    12th Ludwig Boltzmann Forum Tokyo 2020
    12th Ludwig Boltzmann Forum Tokyo 2020. Hiromitsu Nakauchi (Professor at Stanford University and Tokyo University)
    12th Ludwig Boltzmann Forum Tokyo 2020
    12th Ludwig Boltzmann Forum Tokyo 2020. Hiromitsu Nakauchi (Professor at Stanford University and Tokyo University)
    12th Ludwig Boltzmann Forum Tokyo 2020
    12th Ludwig Boltzmann Forum Tokyo 2020. Hiromitsu Nakauchi (Professor at Stanford University and Tokyo University)
    12th Ludwig Boltzmann Forum Tokyo 2020
    12th Ludwig Boltzmann Forum Tokyo 2020. Satoshi Nagata (NTT DOCOMO Inc., 3GPP TSG-RAN Vice-Chairman)
    12th Ludwig Boltzmann Forum Tokyo 2020
    12th Ludwig Boltzmann Forum Tokyo 2020. Satoshi Nagata (NTT DOCOMO Inc., 3GPP TSG-RAN Vice-Chairman)
    12th Ludwig Boltzmann Forum Tokyo 2020
    12th Ludwig Boltzmann Forum Tokyo 2020. Satoshi Nagata (NTT DOCOMO Inc., 3GPP TSG-RAN Vice-Chairman)
    12th Ludwig Boltzmann Forum Tokyo 2020
    12th Ludwig Boltzmann Forum Tokyo 2020
    12th Ludwig Boltzmann Forum Tokyo 2020
    12th Ludwig Boltzmann Forum Tokyo 2020
    12th Ludwig Boltzmann Forum Tokyo 2020
    12th Ludwig Boltzmann Forum Tokyo 2020. Speakers: Masaki Ogata (Vice-Chairman JR-East Railway Company), Hiromitsu Nakauchi (Professor at Stanford University and Tokyo University), Gerhard Fasol (Creator and Chair, Ludwig Boltzmann Forum), Masashi Yanagisawa (Professor Tsukuba University and Director of the International Institute for Integrative Sleep Medicine), Satoshi Nagata (NTT DOCOMO Inc., 3GPP TSG-RAN Vice-Chairman) (from left to right)
    12th Ludwig Boltzmann Forum Tokyo 2020
    12th Ludwig Boltzmann Forum Tokyo 2020. Masashi Yanagisawa (Professor Tsukuba University and Director of the International Institute for Integrative Sleep Medicine), Masaki Ogata (Vice-Chairman JR-East Railway Company), (from left to right)
    12th Ludwig Boltzmann Forum Tokyo 2020
    12th Ludwig Boltzmann Forum Tokyo 2020. Speakers: Hiromitsu Nakauchi (Professor at Stanford University and Tokyo University), Masashi Yanagisawa (Professor Tsukuba University and Director of the International Institute for Integrative Sleep Medicine), Masaki Ogata (Vice-Chairman JR-East Railway Company), Gerhard Fasol (Creator and Chair, Ludwig Boltzmann Forum) (from left to right)

    contact

      Copyright (c) 2020 Eurotechnology Japan KK All Rights Reserved

    • Gerhard Fasol: today’s agenda. Entropy, information and Ludwig Boltzmann – and Japan’s economic growth

      Gerhard Fasol: today’s agenda. Entropy, information and Ludwig Boltzmann – and Japan’s economic growth

      Gerhard Fasol: today’s agenda. Entropy, information and Ludwig Boltzmann – and Japan’s economic growth, 12th Ludwig Boltzmann Forum, 20 February 2020

      Gerhard Fasol, CEO , Eurotechnology Japan KK. Guest Professor, Kyushu University, former faculty Cambridge University, and Trinity College, and Tokyo University

      Purpose of the Ludwig Boltzmann Forum

      • Leadership Forum based on logic, science and technology.
      • Create impact and change
      • Contribute to solutions of important issues which make a difference to our lives
      • “Superstar leaders” as keynote speakers

      Today’s program:

      • Increased economic growth from increasing international cooperation between Japan and Europe, eg in the fields of railways, sleep, genetics, 5G and 6G communications, in research and business
      • Governance and management of companies – growth of companies must improve for economic growth and to pay for the costs of an aging society
      • Research, development, and Universities are key for economic growth – they must improve to recover economic growth. We can learn from Ludwig Boltzmann

      Some of Japan’s top issues and opportunities

      • Japan’s economy stopped growing in 2000. A new business model is needed for Japan. Japan has many fantastic technologies, products, business models with big opportunities for global value creation.
      • Aging society.
      • University reform is urgently necessary in order to restart growth.
      • Company management and supervision reform is urgently necessary. About 1/2 of TOPIX companies have market capitalization lower than book value, and too many Japanese companies have no growth and no profits since 2000, and no growth of market capitalization/company value since 2000.

      Some results which might areas from today’s conference

      • Safety is top priority for JR-East and sleep of managers and driving staff is a primary factor for safety and accident prevention. Today we have the leader of JR-East, and a top global leader in sleep science, maybe today’s conference can lead to cooperation, joint research or development with JR-East on sleep and safety.
      • 5G and 6G communications will impact all areas of society, how can society influence the development of 5G and 6G services and ecosystems. Society and 5G/6G ecosystems evolve in sync.
      • We are at the start of a novel virus crisis, how will an epidemic affect mobility, communications, sleep, medicine.

      Family background: Boltzmann & Chiari

      Johann Baptist Chiari (1817-1854)

      Gynecologist & Obstetrician 産婦人科医

      Professor in Prag and Vienna

      https://de.wikipedia.org/wiki/Johann_Baptist_Chiari

      https://en.wikipedia.org/wiki/Johann_Baptist_Chiari

      Johann Baptist Chiari in the Official History of Vienna:

      https://www.geschichtewiki.wien.gv.at/Johann_Baptist_Chiari

      Ottokar Chiari (1853-1918)

      Ear Nose and Throat specialist, laryngologist, rhino laryngologist 耳鼻咽喉専門医

      Professor and Director of the Ortorhinolaryngological University Clinic at Vienna University. Ottokar Chiari performed the first transbronchial operation, introducing minimal-invasive surgery.

      In 1912 he introduced the transethmoid trans-sphenoid operation.

      He founded the Ear-Nose-Throat Clinic (Ortorhinolaryngological University Clinic) at the University of Vienna, the first Ear-Nose-Throat (Ortorhinolaryngological University Clinic) worldwide, of which he was appointed Director (Leiter der Laryngoloischen Abteilung der Allgemeinen Krankenhauses) from 1900 and Chair Professor (ordentlicher Professor) from 1912.

      Ottokar Chiari was appointed the personal medical doctor of Emperor Franz-Joseph, and was elevated to the status of “Freiherr” in 1917.

      Ottokar Chiari (Ottokar Freiherr von Chiari) is the son of Johann Baptist Chiari. His daughter Paul Chiari married the son of Ludwig Boltzmann, and is my (Gerhard Fasol’s) grandmother.

      Ottokar Chiari in the Official History of Vienna

      https://www.geschichtewiki.wien.gv.at/Ottokar_Chiari

      Since 23 March 1932, Chiarigasse in Wien-Favoriten is named after Ottokar Freiherr von Chiari, see Vienna’s official history: https://www.geschichtewiki.wien.gv.at/Chiarigasse

      https://de.wikipedia.org/wiki/Ottokar_von_Chiari

      https://en.wikipedia.org/wiki/Ottokar_Chiari

      Hans Chiari (1851-1916)

      Pathologist

      Pathologist 病理医

      University of Strasbourg: Professor and University President 

      Hans Chiari in the official History of Vienna https://www.geschichtewiki.wien.gv.at/Hans_Chiari

      https://de.wikipedia.org/wiki/Hans_Chiari

      https://en.wikipedia.org/wiki/Hans_Chiari

      Karl Chiari (1912-1982)

      Karl Chiari is the son of Richard Chiari (1882-1929), Director of the Linz General Hospital (Allgemeines Krankenhaus Linz). Karl Chiari is the founder of orthopedics in Vienna, he was the first head of the new Department of Orthopaedics at the University Hospital Vienna.

      Karl Chiari pioneered many new modern therapies and surgery methods in the field of Orthopaedics. He pioneered therapies and treatments in the fields of Scoliosis (a medical condition where a patient’s spine is curved sideways), bone tumors, orthopaedic rheumatology, knee entroprothetic, hip endoprotethic, and operations to correct hip dysplasia.

      In 1967, Karl Chiari became Chair Professor (ordentlicher Professor), and since 1962 he was the first Director of the Orthopaedic Clinic at the Vienna University Hospital., which spun out from the 1. Surgical University Clinic at the University of Vienna. He was Director of the Orthopaedic Clinic for 20 years.

      Today at the Medical University Vienna (MedUni Wien) the Laboratory for Orthopaedic Biology is named Karl Chiari Lab for Ortopaedic Bilogy in honor of Karl Chiari, https://www.meduniwien.ac.at/hp/orthopaedie/forschung/karl-chiari-lab-for-orthopaedic-biology/mission-statement/

      As children we used to ski together with Karl Chiari’s family, and at the age of 6 years I (Gerhard Fasol) broke my leg while skiing together with Karl Chiari and his children. Back in the farm house pension where we all stayed, Karl Chiari adjusted my broken bones with his hands, and put my legs in plaster, which he always had with him. Later in his Clinic in Vienna, he x-rayed my broken leg, made more adjustments, put on a proper longer time plaster, and oversaw my leg until it was properly healed.

      More about Karl Chiari:

      official history of Vienna: https://www.geschichtewiki.wien.gv.at/Karl_Chiari_(Orthopäde)

      https://www.oeaw.ac.at/fileadmin/Institute/INZ/Bio_Archiv/bio_2012_06.htm

      https://www.meduniwien.ac.at/hp/orthopaedie/forschung/karl-chiari-lab-for-orthopaedic-biology/who-was-karl-chiari/

      Ludwig Boltzmann 20 February 1844 – 5 September 1906

      • Physicist
      • Mathematician
      • Philosopher
      • Leader
      • Venture investor (air planes)

      The Ludwig Boltzmann Forum is a platform of leaders driving improvements based on logic and science

      • inspire leaders by Ludwig Boltzmann’s example
      • honesty, humility
      • asking profound questions and working towards the answers using logic, mathematics, science
      • understand nature and systems

      Ludwig Boltzmann in the official history of Vienna https://www.geschichtewiki.wien.gv.at/Ludwig_Boltzmann

      We use Ludwig Boltzmann’s results and tools every day

      as examples

      • S = k log W – linking macroscopic entropy to statistics of molecules > information theory: Shannon entropy
      • Boltzmann transport equations > optimal transport
      • Definition of Kelvin, Celsius directly linked to Boltzmann constant
      • Stefan-Boltzmann radiation law
      • statistical mechanics and Maxwell-Boltzmann statistics
      • Philosophy of nature: is the space we live in curved? How can we determine the curvature of our space? Using philosophy – or using the tools of physics and mathematics?

      Ludwig Boltzmann was several times proposed for the Nobel Prize 1903, 1905 and three times in 1906 – the year he passed away.

      Ludwig Boltzmann started young

      1865, at the of age of 21 years he published his first scientific work: “Über die Bewegung der Elektrizität in krummen Flächen” (Electricity on curved surfaces).

      About 20% of Boltzmann’s publications were in the field of electro-magnetism. 1861-1862 James Clerk Maxwell had created the foundations of modern electro-magnetism with Maxwell’s equations.

      Linking the initially macroscopic 2nd law of thermodynamics to the statistical mechanics of atoms and molecules governed by Newton’s laws

      1866 at the age of 22 years Ludwig Boltzmann published one of his most important works in a field he created and worked on for all his life: “Über die mechanische Bedeutung des zweiten Hauptsatzes der Wärmetheorie” (About the mechanical meaning of the second law of thermodynamics).

      https://reader.digitale-sammlungen.de//en/fs1/object/display/bsb10133426_00003.html

      As a reminder: the 2nd law of thermodynamics says that an isolated system spontaneously evolves to the state of greatest entropy. The 2nd law of thermodynamics was first formulated by Sadi Carnot in 1824 as part of the efforts to optimize steam engines and is also known as Carnot’s theorem.

      Boltzmann linked this initially macroscopic law to the statistical mechanics of atoms and molecules governed by Newton’s laws at a time when the existence of atoms was not yet generally accepted.

      Boltzmann’s dilemma: how can time-reversible Newton’s laws at the microscale lead to the time-irreversible 2nd law of thermodynamics

      Newton laws govern the microscopic collisions and motion of atoms and molecules in gases and are completely time reversible. Processes we observe macroscopically, e.g. a gas escaping from a pressure vessel, are time irreversible. This dilemma, how Newton’s reversible laws governing the microscopic motion can lead to irreversible processes on the macroscopic scale, occupied Boltzmann’s mind and work his whole life long. Boltzmann’s answers depend on the realization that the 2nd law of thermodynamics cannot be explained by Newton’s laws of mechanics alone, but the mathematical tools of statistical mechanics are required, many of which Boltzmann created.

      Boltzmann’s path through life: starting young – and global

      • 1865 (age 21) first publication “Electricity on curved surfaces”
      • 1867-1869 (age 23-25) Privat-Dozent (Associate Professor)
      • 1869-1873 (age 25) Full Professor, Mathematical Physics, University of Graz
      • 1873-1876 (age 29) Full Professor, Mathematics, University of Vienna
      • 1875 (age 31) declined offer of Professorship in Zürich and Freiburg (Germany)
      • 1876-1890 (age 32) marriage, Full Professor for Experimental Physics and Head of the Institute of Physics, University of Graz
      • 1887-1888 (age 43-44) Rector (President), University Graz
      • 1888 (age 44) March: Professor in Berlin, June: resigned from Professor position
      • 1890 (age 46) Professor in München (one of his students was Nagaoka Hantaro, who later became the first President of Osaka University, and created a model of the atom)
      • 1892 attended 300 year celebrations of Trinity College Dublin
      • 1894 visit to Oxford University
      • 1894-1990 (age 50) Professor, University of Vienna
      • 1895 attending Naturforscherversammlung in Lübeck
      • 20 June – 2 August 1889 (age 55) first trip to the USA: Clark University, Worcester MA, Boston, Montreal
      • 1900-1902 (age 56) Professor of Theoretical Physics in Leipzig
      • 1902-1906 (age 58) Professor of Theoretical Physics at University Vienna
      • Trips to Göttingen, Kassel, Southport Meeting of the British Association for the Advancement of Science and to Paris.
      • 1903/1904 Vorlesungen über Naturphilosophie (Lectures on philosophy of nature)
      • 21 August – 8 October 1904 second trip to the USA to attend St Louis World Fair and Congress “Physics for a new century”, Detroit, Chicago, Washington DC
      • 11 June – 3 August 1905 third trip to the USA: Lectures at the University of California Berkeley and at Stanford University

      What can we learn from Ludwig Boltzmann?

      • Empower young people, recognize and support talent early
        • LB published first scientific work at age 21
        • Full Professor at 25
        • Head of Department at 32
        • President of University at 43
      • Talent is not linear – talent is exponential
      • Move around the world. Connect. Interact.
      • Empower women (LB promoted many women)
      • Don’t accept authority for authority’s sake
      • Science/physics issues need to be treated with the methods of physics/science
      • No dogmas
      • Support entrepreneurs (LB supported airplane developers before airplanes existed)

      Summary: understanding and learning from Ludwig Boltzmann

      Boltzmann’s results are a big part of our understanding of the world and the universe

      His mathematical tools are used every day by today’s engineers, bankers, IT people, physicists…

      LB stood up for his ideas and conclusions and did not accept scientific authorities for authorities’ sake

      12th Ludwig Boltzmann Forum, 20 February 2020
      12th Ludwig Boltzmann Forum, 20 February 2020
      12th Ludwig Boltzmann Forum, 20 February 2020
      12th Ludwig Boltzmann Forum, 20 February 2020
      12th Ludwig Boltzmann Forum, 20 February 2020
      12th Ludwig Boltzmann Forum, 20 February 2020
      12th Ludwig Boltzmann Forum, 20 February 2020
      12th Ludwig Boltzmann Forum, 20 February 2020

      contact

        Copyright (c) 2020 Eurotechnology Japan KK All Rights Reserved

      • Masaki Ogata: Open Innovation and MaaS of JR East

        Masaki Ogata: Open Innovation and MaaS of JR East

        Masaki Ogata: Open Innovation and MaaS of JR East

        12th Ludwig Boltzmann Forum, 20 February 2020

        Summary by Gerhard Fasol

        Masaki Ogata: Open Innovation and MaaS of JR East, 12th Ludwig Boltzmann Forum, 20 February 2020
        Masaki Ogata: Open Innovation and MaaS of JR East, 12th Ludwig Boltzmann Forum, 20 February 2020

        Masaki Ogata

        • East Japan Railway Company, Board Director and Vice-Chairman, Executive Vice President of Technology & Overseas Related Affairs
        • Honorary President, UITP (International Association of Public Transport)
        • Member of Council for Science and Technology, Chairperson of Subdivision on Professional Engineers, Ministry of Education, Culture, Sports, Science and Technology Japan
        • Chairman & CEO, Japan Institute of IT
        • Chairman Tohoku Tourism Promotion Organization
        • Director Tohoku Electric Power Company Inc.

        Summary: Open Innovation and MaaS of JR East

        With 17.9 million passengers/day, 12,209 trains/day on a network of 7402 km, JR-East is one of the largest railway companies in the world. JR-East is a fully integrated group including ownership, manufacture and maintenance of rolling stock, infrastructure including track, stations and real-estate, trains and buses, and life-style business, and one of the first and most advanced fin-tech systems globally: electronic payment systems and electronic money.

        JR-East receives no government subsidies, and had no fare or charge increases for 33 years (except for increases in the consumption tax).

        JR-East is constantly innovating, developing MaaS, deepening fin-tech and mobile payments, and increasing Shinkansen speeds to 360 km/h.

        Mr Ogata sees the MaaS revolution as a revolutionary economic wave occurring once in 100 years, and works for JR-East to drive this Maas wave.

        7 Features of JR East Management

        Vertical structure
        • (1) non-rail business: life-style business, IC card
        • (2) operation: trains and busses
        • (3) maintenance: rolling stock and infrastructure
        • (4) ownership: rolling stock and infrastructure
        Horizontal structure

        Passengers: 17.9 million/day – largest number of passengers globally

        Network: 7402 km

        Trains: 12,209 trains/day

        • (5) Shinkansen
        • (6) Tokyo region
        • (7) regional lines in North-Eastern Japan
        Business Structure

        17.9 million customers / day (largest in the world)

        FY2018 Revenues: € 24.6 billion

        • Transportation business: € 16.7 billion (68%)
          • Tokyo metropolitan 58%
          • Shinkansen 29%
          • Regional 3%
          • other transportation (bus, monorail etc) 9%
        • Life service business: €7.9 billion (32%)
        Safety is always the top priority of JR East management
        Multiple business models

        a mobility company, covering 24 hours and all the life of people. Synergetic growth with railways as the base and towards Mobility as a Service (MaaS)

        1. Railway
        2. Life style (shops, buildings…)
        3. Micropayment
        4. Rolling stock manufacture
        5. Overseas business

        Public Transport (PT) in Japan and in the world

        • railway companies – Japan: 200, globally: 3000
        • bus companies – Japan: 7000, globally: 80,000
        • taxi companies – Japan: 16,000, globally: 200,000
        • (taxi cars in Japan: approx. 260,000)

        Public Transport (PT) leads Mobility as a Service (MaaS)

        • PT innovation
        • improvement by intermodal cooperation (e.g. JR-East through trains to other railways companies and Tokyo subways)
        • integration with new mobility solutions

        STTT Model (Shortening Total Trip Time = STTT)

        Customers are mainly interested in the total trip time. Shorten total trip time by reducing the time of each component of the trip, and in particular access to public transport at both ends (e.g. by bicycle, moped or “new personal mobility” e.g. shared electro-scooters etc), and shorten transitions between different means of transport.

        Maximum transport capacity per direction per hour:

        • automobile: 1000
        • bus: 2500
        • LRT: 11,000
        • monorail: 21,000
        • mini-metro: 35,000
        • heavy rail, incl. metro: 64,000
        • heavy rail (e.g. JR East Chuo Line): 100,000

        Mobility as a Service (MaaS): a once-in-a-century wave of change including the public transport (PT) industry

        We see the development of Mobility as a Service (MaaS) as a massive once-in-a-century change of paradigm which includes the public transport (PT) industry

        We see an evolution from privately owned, manually operated automobiles to sharing, on-demand, autonomous operation integrated with public transport. Current public transport + new concepts such as UBER, Lyft, in Japan “Times Car Plus” integrating with innovations in public transport.

        Once in 100 years wave of change in transportation (MaaS) is a threat to the automobile industry

        the new paradigm CASE was always the case for the railway industry:

        • Connected
        • Autonomous
        • Shared
        • Electric

        Many industries aim at becoming the dominating MaaS platform

        We see a big threat to the automobile industry from several directions:

        • data businesses may overwhelm automobile companies
        • automobile companies may decline into commodity manufacturing
        • customer needs (and value to the customer) will shift from the product (car) itself to mobility service

        Mobility wave as economic cycle

        Open Innovation of JR East

        (1) innovation of operations
        • Speed-up of Shinkansen
          • 1987 operation speed = 240 km/h
          • 2019 operation speed = 320 km/h
          • 2019 test speed = 400 km/h
          • aiming at operation speed of 360 km/h
        • Number of trains
          • 1987: 11,175 trains/day
          • 2019: 12,209 trains/day (+ 9.3%)
        • Enhancement of sustainability
          • average CO2 emission per railway passenger
            • 1/7 of automobiles
            • 1/5 of airplanes
            • JR East: 1/2 of global rail average
        • Enhanced efficiency of train operations
          • 1987: 71,000 staff in JR East’s Railway Operation Division
          • 2019: 39,000 staff
        (2) IT innovation
        • Number of IT systems
          • 1987: 3 IT systems
          • 2019: 1224 IT systems
        • Big Data and Condition Based Maintenance (CBM)
          • CBM is now being introduced for track, rolling stock, electric facilities…
        • IT for customer service: “JR East App”
          • Japanese version: 4.8 downloads
          • Multi-lingual version (English/Chinese/Korean): 500,000 downloads (as of January 2020)

        No government subsidies and no fare/charge increases for 33 years

        For the past 33 years (since 1987):

        • no subsidies from central or local governments
        • no increased fares or charges (except for consumption tax increases)

        Examples of innovation: SUICA and fintech since November 2001

        Evolution from analog paper tickets to fintech
        • paper tickets (analog)
        • magnetic ticketing cards stage 1: NRZ1 (non-return-to-zero) (these tickets have a brown backside)
        • magnetic ticketing cards stage 2: FM (F2F) (Frequency modulation) (these tickets have a black backside)
        • magnetic cards for stored fares (SF)
        • SUICA IC Chip memory since 18 November 2001
        • Authentication, micropayments > fintech from March 2004
        • Mobile SUICA integration with mobile phones, start: January 2006
        • development of new business
        SUICA started on 18 November 2001: an example of open innovation

        SUICA: cooperation between JR East and SONY

        • transactions in 200 milli-seconds
        • ticketing
        • commuter passes
        • micropayments
        • mobile SUICA

        Open strategy

        • technical disclosure to industry peers: disclosure to more than 200 railway companies in Japan
        • standardization of the technology – de-facto standards:
          • better customer service
          • big impact on society and the nation
          • scale merit: scaling!
        • 23 March 2013: completion of nationwide platform
          • complete mutual usage
          • coverage: 12% of the population
          • 5000 railroad stations
          • 50,000 buses
        Development of SUICA
        • 18 Nov 2001: implemented IC ticketing SUICA in Tokyo
        • 22 March 2004: launched micropayment service (e-money) based on SUICA IC card ticketing system
        • 28 January 2006: launched “mobile SUICA” for feature phones
        • 18 March 2007: interoperable service with PASMO
        • 23 July 2011: launch of Mobile SUICA services for smart phones
        • 23 March 2013: launched interoperable service with 10 regional transport cards for 142 operations, later expanded to currently 258 operating companies
          • interoperable transport IC card systems: total 160 million cards
          • mobile SUICA: 9.0 million members
          • micropayments:
            • maximum transactions/day: 9.58 million
            • transactions per month: 253 million
            • member stores: 850,000 (as of December 2019)

        Micropayment fintech in Japan is driven by SUICA and railroad payment cards:

        3 tsu (通)

        • Tsushin (通信) = communications
        • Kotsu (交通)= transport
        • Ryotsu (流通) = logistics

        It took almost 20 years to move from the initial introduction of IC card based SUICA micropayments for transport on 18 November 2001 to the cashless society policy movement in Japan from 2018.

        MaaS of JR East

        The MaaS platform of JR East aims to include a wide range of business areas:

        • single mode type: automated driving and car sharing
        • integrated type of multi PT modes: bus, railways, Shinkansen
        • integrated type of mobility: bike sharing, rent-a-car, taxi
        • MaaS of JR East platform further includes: restaurants, shopping, hotels, tourism, inns, kiosks, luggage lockers etc
        • telecommunication carriers
        • local government and other services

        MaaS aims for all integrated services = all mobility + any added values with lean start-up and agile development philosophies

        Proof of concept for JRE MaaS

        • Niigata, Shonai area: Niigata MaaS Trial since October 2019
        • Tohoku area: under consideration, PoC from 2012
        • Sendai area: PoC since February 2020
        • Tokyo Metropolitan area: PoC since August 2018, public release from January 2020
        • Izu (Shizuoka Prefecture), PoC in cooperation with local operator Izukyu Corporation.
          • Phase 1: April 2019 – June 2019
          • Phase 2: December 2019 – March 2020

        Future customer journey will provide “24 hours, one-stop” services from wake-up, digital time management to transportation with flexible schedule change, meeting management, and one-stop reservations for transport, restaurants, hotels etc including easy and automatic check-in

        “3D smooth trip”

        • horizontal: through operations
        • vertical: barrier free equipment
        • psychological: smart card in stations and trains with 0.2 second transactions

        4 service levels – MaaS app under PoC

        • Level 1: integration of information: information app and route search engine
        • Level 2: integration of booking and payment, SUICA micropayments
        • Level 3: integration of service offer, bundling, subscriptions, contract, commuter pass and through operations
        • Level 4: integration of national policy, government

        Moving Further Forward

        MTOMI model = Management + Technology + Operation + Maintenance + Infrastructure

        Integrating technology and service industry provides value and service to customers, community, society and the nation.

        The moment of truth is hospitality.

        The Triangle:

        • customers and the moment of truth: hospitality
        • management policy
        • MTOMI model + well-disciplined employees

        Genuine infrastructure = MTOMI Model optimizes multiple resources and services and offers multiple options to consumers

        Integration of the MTOMI Model + sophisticated service provides value to customers, communities, societies, nation and the world > MaaS of JR East

        Public Transport (PT) will lead MaaS

        In the ICT field GAFA (Google, Apple, Facebook, Amazon) and other Silicon Valley and Chinese companies are far ahead, however Japan has unique infrastructure, especially railway infrastructure as unique fields of application for ICT.

        Just Shinjuku station alone is a unique application field.

        Scale and speed are the keys to success.

        ICT and Public Transport (PT) are an excellent match for each other.

        Ultimate mobility means: everyone can move freely at anytime to anywhere with comfort by mobility of high quality

        Masaki Ogata: Open Innovation and MaaS of JR East, 12th Ludwig Boltzmann Forum, 20 February 2020
        Masaki Ogata: Open Innovation and MaaS of JR East, 12th Ludwig Boltzmann Forum, 20 February 2020
        Masaki Ogata: Open Innovation and MaaS of JR East, 12th Ludwig Boltzmann Forum, 20 February 2020
        Masaki Ogata: Open Innovation and MaaS of JR East, 12th Ludwig Boltzmann Forum, 20 February 2020
        Masaki Ogata: Open Innovation and MaaS of JR East, 12th Ludwig Boltzmann Forum, 20 February 2020
        Masaki Ogata: Open Innovation and MaaS of JR East, 12th Ludwig Boltzmann Forum, 20 February 2020
        Masaki Ogata: Open Innovation and MaaS of JR East, 12th Ludwig Boltzmann Forum, 20 February 2020
        Masaki Ogata: Open Innovation and MaaS of JR East, 12th Ludwig Boltzmann Forum, 20 February 2020
        Masaki Ogata: Open Innovation and MaaS of JR East, 12th Ludwig Boltzmann Forum, 20 February 2020
        Masaki Ogata: Open Innovation and MaaS of JR East, 12th Ludwig Boltzmann Forum, 20 February 2020
        Masaki Ogata: Open Innovation and MaaS of JR East, 12th Ludwig Boltzmann Forum, 20 February 2020
        Masaki Ogata: Open Innovation and MaaS of JR East, 12th Ludwig Boltzmann Forum, 20 February 2020
        Masaki Ogata: Open Innovation and MaaS of JR East, 12th Ludwig Boltzmann Forum, 20 February 2020
        Masaki Ogata: Open Innovation and MaaS of JR East, 12th Ludwig Boltzmann Forum, 20 February 2020
        Masaki Ogata: Open Innovation and MaaS of JR East, 12th Ludwig Boltzmann Forum, 20 February 2020
        Masaki Ogata: Open Innovation and MaaS of JR East, 12th Ludwig Boltzmann Forum, 20 February 2020
        Masaki Ogata: Open Innovation and MaaS of JR East, 12th Ludwig Boltzmann Forum, 20 February 2020
        Masaki Ogata: Open Innovation and MaaS of JR East, 12th Ludwig Boltzmann Forum, 20 February 2020
        Masaki Ogata: Open Innovation and MaaS of JR East, 12th Ludwig Boltzmann Forum, 20 February 2020
        Masaki Ogata: Open Innovation and MaaS of JR East, 12th Ludwig Boltzmann Forum, 20 February 2020

        contact

          Copyright (c) 2020 Eurotechnology Japan KK All Rights Reserved

        • Masashi Yanagisawa: Solving the Mysteries of Sleep: Toward the Real-World Implementation of Sleep Science

          Masashi Yanagisawa: Solving the Mysteries of Sleep: Toward the Real-World Implementation of Sleep Science

          Masashi Yanagisawa: Solving the Mysteries of Sleep: Toward the Real-World Implementation of Sleep Science, 12th Ludwig Boltzmann Forum, 20 February 2020

          Masashi Yanagisawa, International Institute for Integrative Sleep Medicine (WPI-IIIS), Director, University of Tsukuba, Professor

          Professor Yanagisawa is founder and Director of the International Institute for Integrative Sleep Medicine (IIIS), which he founded and is leading to study sleep – one of the most important puzzles of nature. He build the IIIS based on his long work at the University of Texas Southwestern Medical Center, and learning from the principles guiding departments at major US Universities.

          Summary by Gerhard Fasol

          Solving the mysteries of sleep: what physically is “sleepiness”?

          Tokyo is the world’s most sleep-insufficient city with 5 h 28 mins/night

          The world’s most sleep-insufficient city is Tokyo – actigraphy shows that the average sleep time in Tokyo is 5 hours 28 minutes – and this is unsustainable. (GF: see notes towards the end of this page)

          A study by the sleep app company SleepCycle and mentioned in The Economist/1843 magazine shows average time in bed per day based on 1 million users of the SleepCycle app vs GDP/person for 55 countries (see notes below for sources). While New Zealand, Finland and Netherlands show similar GDP/person, their time in bed is longest 0n the order of 7 h 45 mins/night, while South Korea and Japan are at the bottom of the figure with time in bed around 6 h 15 mins to 6 h 30 mins.

          Lack of sleep is estimated to cost Japan about US$ 138 billion (3% of GDP) annually

          The study “Why Sleep Matters: Quantifying the Economic Costs of Insufficient Sleep” by RAND Europe

          https://www.rand.org/randeurope/research/projects/the-value-of-the-sleep-economy.html

          estimates that insufficient sleep costs Japan about US$ 138 billion (about 3% of GDP) annually. While less dramatic, sleep in other major industrial countries is also insufficient, and ist estimated to cost Germany about 1.6%, UK 1.9%, the USA 2.3%, and Canada 1.3% of GDP.

          Lack of sleep causes a decrease of performance similar to alcohol intoxication

          Dawson and Reid in study compared the decrease of performance caused by extended wakefulness with that caused by alcohol intoxication, and found that 17 hours of sustained wakefulness (e.g. from 7am to midnight) causes a drop in performance similar that caused by a blood alcohol concentration of 0.05%.

          Wakefulness of 24 hours (e.g. from 7am until 7am the next day) leads to performance reduction corresponding to a blood alcohol concentration of 0.1%.

          reference: Dawson, D., Reid, K. Fatigue, alcohol and performance impairment. Nature 388, 235 (1997)

          https://doi.org/10.1038/40775

          https://www.nature.com/articles/40775

          The neurobiological “cost” of sleep reduction accumulates, and sleep deprived individuals underestimate this cost

          Van Dongen et al show that the “cost” of short sleep, “sleep debt” accumulates, and is systematically underestimated by individuals as a consequence of insufficient sleep.

          reference: Van Dongen HP, Maislin G, Mullington JM, Dinges DF. The cumulative cost of additional wakefulness: dose-response effects on neurobehavioral functions and sleep physiology from chronic sleep restriction and total sleep deprivation. Sleep, Volume 26, Issue 2, March 2003, Pages 117–126,

          https://doi.org/10.1093/sleep/26.2.117

          https://academic.oup.com/sleep/article/26/2/117/2709164

          Healthy young individuals are at risk of accumulating “sleep debt”, from which it is hard to recover

          Laboratory experiments show that healthy young individuals are at risk of sleeping one hour/day less than optimal, and a 1 hour “sleep debt” takes 4 days of optimum sleep to recover to full performance.

          reference: Shingo Kitamura, Yasuko Katayose, Kyoko Nakazaki, Yuki Motomura, Kentaro Oba, Ruri Katsunuma, Yuri Terasawa, Minori Enomoto, Yoshiya Moriguchi, Akiko Hida & Kazuo Mishima, Estimating individual optimal sleep duration and potential sleep debt, Sci Rep 6, 35812 (2016).

          https://doi.org/10.1038/srep35812

          https://www.nature.com/articles/srep35812

          Short sleep duration is independently associated with prevalent and incident atrial fibrillation

          Lack of sleep is associated with atrial fibrillation. Atrial fibrillation is associated with increased risk of heart failure, dementia, and stroke.

          reference: Michael V. Genuardi MD, Rachel P. Ogilvie, PhD, MPHb,Aisha Rasool Saand, MD, Rebecca S. DeSensi, BA, Melissa I. Saul, MS, Jared W. Magnani, MD, Sanjay R. Patel, MD, Association of Short Sleep Duration and Atrial Fibrillation, Chest, (September 2019) Volume 156, Issue 3, Pages 544–552

          https://doi.org/10.1016/j.chest.2019.01.033

          https://journal.chestnet.org/article/S0012-3692(19)30196-5/

          Do all animals sleep? When in evolution did sleep develop? Do animals without a centralized nervous system sleep?

          How far back in Darwin’s evolution did sleep develop? Sleep has been observed in a wide range of animals, in worms, flies, zebrafish and mice. Although it’s hard to prove scientifically, its likely that all animals with a central nervous system sleep, however sleep patterns differ.

          Do animals without a centralized nervous system sleep?

          Three characteristics define sleep:

          1. a period of decreased activity
          2. reduced responsiveness to stimuli
          3. homeostatic regulation

          Ravi et al demonstrated sleep in “upside down jellyfish”, Cassiopea jellyfish, which belong to the Cnidaria evolutional lineage. These have a non-centralized nerve net, but no centralized nervous system or brain.

          Cassiopea pulse by relaxing and contracting their bell about 1 pulse per second. Nath et al observed this pulse for a large number of Cassiopea jellyfish with an imaging system, and found that Cassiopea pulse less during night than during day, this sleep state is rapidly reversible, and shows all other characteristics of sleep.

          Thus it seems that sleep arose before the evolution of a centralized nervous system.

          see: Ravi D. Nath, Claire N. Bedbrook, Michael J. Abrams, Ty Basinger, Justin S. Bois, David A. Prober, Paul W. Sternberg, Viviana Gradinaru, and Lea Goentoro, The Jellyfish Cassiopea Exhibits a Sleep-like State, Current Biology 27, 2984–2990, (October 9, 2017)

          http://dx.doi.org/10.1016/j.cub.2017.08.014

          https://www.cell.com/current-biology/fulltext/S0960-9822(17)31023-0

          Motivation and sleep

          Lazarus/Oishi Laboratory (International Institute for Integrative Sleep Medicine WPI-IIIS)

          https://www.wpiiiislazaruslab.org

          Sleep is understood to be driven by two factors:

          However, we all know that motivation, emotion also influence sleep.

          Why are we sleepy when we are bored?

          The Nucleus Accumbens (NAc) is located close to the hypothalamus (which links the nervous system to the endocrine system and regulates processes in the autonomous nervous system) in our brains, and contributes to processing motivation, aversion, reward, and is also involved in inducing slow-wave sleep.

          The Nucleus Accumbens (NAc) links motivation and sleep.

          Adenosine A2A acting on the NAc via A2A-Receptors (A2AR) induces slow-wave sleep. Chemogenetic inhibition of NAc neurons suppresses sleep. A2A receptors allow sleep gating.

          Motivational stimuli act on the NAc via Dopamine as a neurotransmitter.

          References

          Orexin (= hyprocretin) controls arousal, sleep and appetite – discovered by Masashi Yanagisawa’s and Lecea and Kilduff et al. groups

          Orexin is a neuropeptide controlling arousal, sleep and appetite and was discovered in 1998 simultaneously by two independent groups of researchers: Masashi Yanagisawa’s group named this newly discovered neuropeptide “orexin”, while Lecea and Kilduff et al’s group named it “hypocretin”.

          • Masashi Yanagisawa’s lab at the University of Texas Southwestern Medical Center at Dallas: Takeshi Sakurai, Akira Amemiya, Makoto Ishii, Ichiyo Matsuzaki, Richard M Chemelli, Hirokazu Tanaka, S. Clay Williams, James A Richardson, Gerald P Kozlowski, Shelagh Wilson, Jonathan R.S Arch, Robin E Buckingham, Andrea C Haynes, Steven A Carr, Roland S Annan, Dean E McNulty, Wu-Schyong Liu, Jonathan A Terrett, Nabil A Elshourbagy, Derk J Bergsma, Masashi Yanagisawa, Orexins and Orexin Receptors: A Family of Hypothalamic Neuropeptides and G Protein-Coupled Receptors that Regulate Feeding Behavior, Cell, 92, 573-585 (Feb 20, 1998)
          • L. de Lecea, T. S. Kilduff, C. Peyron X.-B. Gao, P. E. Foye, P. E. Danielson, C. Fukuhara, E. L. F. Battenberg, V. T. Gautvik, F. S. Bartlett, II, W. N. Frankel, A. N. van den Pol, F. E. Bloom, K. M. Gautvik, and J. G. Sutcliffe, The hypocretins: Hypothalamus-specific peptides with neuroexcitatory activity, Proc Natl Acad Sci USA. (1998) Jan 6; 95(1): 322–327.
          Orexin (Public domain according to Wikipedia: Boghog2 grants anyone the right to use this work for any purpose, without any conditions, unless such conditions are required by law.)
          Orexin (hypocretin) neuropeptide precursor (Public domain according to Wikipedia: Boghog2 grants anyone the right to use this work for any purpose, without any conditions, unless such conditions are required by law.)

          Source of this picture: Wikipedia. This work has been released into the public domain by its author, Boghog2 at the Wikipedia project. This applies worldwide. In case this is not legally possible: Boghog2 grants anyone the right to use this work for any purpose, without any conditions, unless such conditions are required by law.

          Narcolepsy: “sleep attacks”

          Narcolepsy is a sleep disorder, where wake-sleep cycle control is defective. Narcolepsy is a serious disorder, where patients can be affected by “sleep attacks”, sudden sleep during daytime, a pathological intrusion of REM sleep into wakefulness.

          Sarah Elizabeth very generously published to following video on YouTube for educational purposes, to show us a narcolepsy “sleep attack”: (source: (c) Sarah Elizabeth on YouTube)

          Peyron et al showed that there is a loss of orexin (hypocretin) in narcolepsy patients.

          references:

          • Christelle Peyron, Juliette Faraco, William Rogers, Beth Ripley, Sebastiaan Overeem, Yves Charnay, Sona Nevsimalova, Michael Aldrich, David Reynolds, Roger Albin, Robin Li, Marcel Hungs, Mario Pedrazzoli, Muralidhara Padigaru, Melanie Kucherlapati, Jun Fan, Richard Maki, Gert Jan Lammers, Constantin Bouras, Raju Kucherlapati, Seiji Nishino & Emmanuel Mignot, A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains, Nat Med 6, 991–997 (2000)

          Sleep/wake switching circuitry

          Scammell et al review the major components of the wake-promoting circuitry (neurons) and the sleep-promoting neurons.

          references

          Orexin agonists and antagonists as potential therapeutics

          Orexins are produced by there hypothalamus and are involved in wakefulness and arousal. Blocking the signaling by Orexins is promising as therapy for insomnia. Orexin receptors as drug targets: towards a therapy for narcolepsy.

          Orexin antagonists for treatment of insomnia.

          • Takashi Nagahara, Tsuyoshi Saitoh, Noriki Kutsumura, Yoko Irukayama-Tomobe, Yasuhiro Ogawa, Daisuke Kuroda, Hiroaki Gouda, Hidetoshi Kumagai, Hideaki Fujii, Masashi Yanagisawa, Hiroshi Nagase, Design and Synthesis of Non-Peptide, Selective Orexin Receptor 2 Agonists, J. Med. Chem. (2015), 58, 20, 7931-7937

          Sleep regulation: sleep need (hours) vs sleep/wake switching (seconds)

          Sleep regulation can be symbolized by a Shishi-odoshi (鹿威し), a bamboo device often found in Japanese gardens. The bamboo is mounted off midway on a pivot, and slowly fills with water. The shorter part of the bamboo tube fills with water from a well, and as it fills, the point is reached where the bamboo tips over suddenly and releases the water. Sleep need similarly build up over time, until the sleep center tips over and we fall asleep suddenly. Assisted by orexin, the arousal center inhibits the sleep center in the brain while we are awake. When we are asleep, the sleep center inhibits the arousal center, and the sleep need decreases while we are sleeping.

          references

          Breading “Sleepy” mice mutants to study the genetics of sleep regulation

          To study the switching mechanisms between wakefulness, REM-sleep and NREM-sleep (REM = Rapid Eye Movement), “sleepy” mice genetic mutants were studied and compared with normal non-sleepy mice.

          references

          • Funato H, Miyoshi C, Fujiyama T, Kanda T, Sato M, Wang Z, Ma J, Nakane S, Tomita J, Ikkyu A, Kakizaki M, Hotta-Hirashima N, Kanno S, Komiya H, Asano F, Honda T, Kim SJ, Harano K, Muramoto H, Yonezawa T, Mizuno S, Miyazaki S, Connor L, Kumar V, Miura I, Suzuki T, Watanabe A, Abe M, Sugiyama F, Takahashi S, Sakimura K, Hayashi Y, Liu Q, Kume K, Wakana S, Takahashi JS, Yanagisawa M. Forward-genetics analysis of sleep in randomly mutagenized mice. Nature 539, 378–383 (2016)

          Solving the mysteries of sleep: International Institute for Integrative Sleep Medicine (IIIS)

          https://wpi-iiis.tsukuba.ac.jp

          Director: Masashi Yanagisawa

          https://wpi-iiis.tsukuba.ac.jp/research/member/detail/masashiyanagisawa/

          Basic concept of IIIS: learning from “departments” in major US Universities.

          1. Strong leadership of “department head”
          2. Appointment of early career PI
          3. Flat personnel hierarchy
          4. Open and mixed research environment
          5. Flexible and dynamic allocation of research resources including floor space
          6. Sharing of large facilities and equipment
          7. Streamlined administrative services

          Notes by Gerhard Fasol

          Japan is the most sleep deprived country of a very long list of major countries

          The American Academy of Sleep Medicine (AASM) and the Sleep Research Society (SRS) in a joint consensus statement say:

          Adults should sleep 7 or more hours per night on a regular basis to promote optimal health”.

          see: Watson NF, Badr MS, Belenky G, Bliwise DL, Buxton OM, Buysse D, Dinges DF, Gangwisch J, Grandner MA, Kushida C, Malhotra RK, Martin JL, Patel SR, Quan SF, Tasali E. Recommended amount of sleep for a healthy adult: a joint consensus statement of the American Academy of Sleep Medicine and Sleep Research Society. SLEEP 2015;38(6):843–844.

          https://www.st-va.ncbi.nlm.nih.gov/pmc/articles/PMC4434546/

          https://dx.doi.org/10.5665%2Fsleep.4716

          https://academic.oup.com/sleep/article/38/6/843/2416939

          sleepcycle.com, which markets the SleepCycle app has been downloaded by 37.4 million people and has tracked 4.38 billion hours of sleep, and publishes statistics on sleep in different countries based on sleep statistics shared by their users/customers.

          In a short report dated December 5, 2014, SleepCycle lists Japan as the No. 1 sleep-deprived country in a list of 20 countries and including the analysis of 351,044 users during 1-30 November 2014. All countries have a minimum of 2000 registered users.

          Average time in bed, 1-30 November 2014, SleepCycle study of Dec 5, 2014:

          1. Japan 5 h 56mins
          2. South Korea 8 h 03mins
          3. Brazil 6 h 37 mins
          4. Mexico 6 h 40 mins
          5. China 6 h 42 mins
          6. Italy 6 h 58 mins
          7. Spain 6 h 58 mins
          8. Germany 7 h 09 mins
          9. Norway 7 h 10 mins
          10. Switzerland 7 h 11 mins
          11. US 7 h 11 mins
          12. Canada 7 h 15 mins
          13. Denmark 7 h 16 mins
          14. Sweden 7 h 16 mins
          15. France 7 h 16 mins
          16. Australia 7 h 20 mins
          17. UK 7 h 22 mins
          18. Belgium 7 h 23 mins
          19. Netherlands 7 h 26 mins
          20. New Zealand 7 h 27 mins

          More detailed data based on 1 million users of SleepCycle were published by The Economist/1843 magazine in the April/May 2018 issue: “Which countries get the most sleep?” The data in this article also show Japan with the shortest length of sleep, about 6 h 20 mins/night at the bottom of a list of 55 major countries. The same SleepCycle data are also shown in a blog article by the World Economic Forum: “Which countries get the most sleep – and how much do we really need?”

          Masashi Yanagisawa: Solving the Mysteries of Sleep: Toward the Real-World Implementation of Sleep Science, 12th Ludwig Boltzmann Forum, 20 February 2020
          Masashi Yanagisawa: Solving the Mysteries of Sleep: Toward the Real-World Implementation of Sleep Science, 12th Ludwig Boltzmann Forum, 20 February 2020
          Masashi Yanagisawa: Solving the Mysteries of Sleep: Toward the Real-World Implementation of Sleep Science, 12th Ludwig Boltzmann Forum, 20 February 2020
          Masashi Yanagisawa: Solving the Mysteries of Sleep: Toward the Real-World Implementation of Sleep Science, 12th Ludwig Boltzmann Forum, 20 February 2020
          Masashi Yanagisawa: Solving the Mysteries of Sleep: Toward the Real-World Implementation of Sleep Science, 12th Ludwig Boltzmann Forum, 20 February 2020
          Masashi Yanagisawa: Solving the Mysteries of Sleep: Toward the Real-World Implementation of Sleep Science, 12th Ludwig Boltzmann Forum, 20 February 2020
          Masashi Yanagisawa: Solving the Mysteries of Sleep: Toward the Real-World Implementation of Sleep Science, 12th Ludwig Boltzmann Forum, 20 February 2020
          Masashi Yanagisawa: Solving the Mysteries of Sleep: Toward the Real-World Implementation of Sleep Science, 12th Ludwig Boltzmann Forum, 20 February 2020
          Masashi Yanagisawa: Solving the Mysteries of Sleep: Toward the Real-World Implementation of Sleep Science, 12th Ludwig Boltzmann Forum, 20 February 2020
          Masashi Yanagisawa: Solving the Mysteries of Sleep: Toward the Real-World Implementation of Sleep Science, 12th Ludwig Boltzmann Forum, 20 February 2020
          Masashi Yanagisawa: Solving the Mysteries of Sleep: Toward the Real-World Implementation of Sleep Science, 12th Ludwig Boltzmann Forum, 20 February 2020
          Masashi Yanagisawa: Solving the Mysteries of Sleep: Toward the Real-World Implementation of Sleep Science, 12th Ludwig Boltzmann Forum, 20 February 2020
          Masashi Yanagisawa: Solving the Mysteries of Sleep: Toward the Real-World Implementation of Sleep Science, 12th Ludwig Boltzmann Forum, 20 February 2020
          Masashi Yanagisawa: Solving the Mysteries of Sleep: Toward the Real-World Implementation of Sleep Science, 12th Ludwig Boltzmann Forum, 20 February 2020
          Masashi Yanagisawa: Solving the Mysteries of Sleep: Toward the Real-World Implementation of Sleep Science, 12th Ludwig Boltzmann Forum, 20 February 2020
          Masashi Yanagisawa: Solving the Mysteries of Sleep: Toward the Real-World Implementation of Sleep Science, 12th Ludwig Boltzmann Forum, 20 February 2020
          Masashi Yanagisawa: Solving the Mysteries of Sleep: Toward the Real-World Implementation of Sleep Science, 12th Ludwig Boltzmann Forum, 20 February 2020
          Masashi Yanagisawa: Solving the Mysteries of Sleep: Toward the Real-World Implementation of Sleep Science, 12th Ludwig Boltzmann Forum, 20 February 2020
          Masashi Yanagisawa: Solving the Mysteries of Sleep: Toward the Real-World Implementation of Sleep Science, 12th Ludwig Boltzmann Forum, 20 February 2020
          Masashi Yanagisawa: Solving the Mysteries of Sleep: Toward the Real-World Implementation of Sleep Science, 12th Ludwig Boltzmann Forum, 20 February 2020
          Masashi Yanagisawa: Solving the Mysteries of Sleep: Toward the Real-World Implementation of Sleep Science, 12th Ludwig Boltzmann Forum, 20 February 2020
          Masashi Yanagisawa: Solving the Mysteries of Sleep: Toward the Real-World Implementation of Sleep Science, 12th Ludwig Boltzmann Forum, 20 February 2020
          Masashi Yanagisawa: Solving the Mysteries of Sleep: Toward the Real-World Implementation of Sleep Science, 12th Ludwig Boltzmann Forum, 20 February 2020
          Masashi Yanagisawa: Solving the Mysteries of Sleep: Toward the Real-World Implementation of Sleep Science, 12th Ludwig Boltzmann Forum, 20 February 2020
          Masashi Yanagisawa: Solving the Mysteries of Sleep: Toward the Real-World Implementation of Sleep Science, 12th Ludwig Boltzmann Forum, 20 February 2020
          Masashi Yanagisawa: Solving the Mysteries of Sleep: Toward the Real-World Implementation of Sleep Science, 12th Ludwig Boltzmann Forum, 20 February 2020

          contact

            Copyright (c) 2020 Eurotechnology Japan KK All Rights Reserved

          • Hiromitsu Nakauchi: Stem cell technology and its potential for future medicine

            Hiromitsu Nakauchi: Stem cell technology and its potential for future medicine

            Hiromitsu Nakauchi: Stem cell technology and its potential for future medicine, Ludwig Boltzmann Forum, 20 February 2020

            Hiromitsu Nakauchi, Stanford University School of Medicine, Professor, and University of Tokyo, Project Professor, Divn. of Stem Cell Therapy, Institute of Medical Science

            Summary by Gerhard Fasol

            Summary: solving the shortage of organ donors and immune rejection with stem cells

            There are far more patients requiring organ transplants than organ donations. Transplanted organs are rejected by the recipient’s immune system requiring life-long immune suppression. Professor Nakauchi explains his path towards growing organs based on a patient’s stem cells injected into an animal’s embryo, which then is implanted into a host animal, and when fully grown this organ is transplanted back into the patient. While this long term target is still very difficult and far in the future, Professor Nakauchi and his teams at Tokyo University and Stanford University have solved several of the intermediary steps, bringing this final target closer.

            What are stem cells?

            Stem cells are undifferentiated or partly differentiated cells at the origin of cell lineages, can develop into different types of cells, and can divide to create more of the same stem cells. Stem cells were found in the 1960s by Ernest McCulloch and James Till’s group at the University of Toronto/Canada.

            see: A. J. Becker, E. A . McCulloch, J. E. Till, Cytological Demonstration of the Clonal Nature of Spleen Colonies Derived from Transplanted Mouse Marrow Cells, Nature 197, 452-454 (1963)

            Stem cells are important for development, maintenance and tissue recovery in our bodies.

            Hierarchy of stem cells

            Embryonic stem (ES) cells

            Embryonic stem cells can be cultured indefinitely, have high differentiation potential (e.g into neurons, muscle cells, blood cells, liver cells etc), and gene manipulation is possible.

            However, ES cells cannot be established from patients and may not represent a healthy individual. In addition there are ethical difficulties regarding the manipulation of human embryos.

            Because ES cells cannot be established from the patient, ES cell based therapy requires Human leukocyte antigen (HLA) matching, and may lead to immune rejection and / or infections.

            Cell therapy using a patient’s own cells is desired, by generating pluripotent stem cells from patients.

            Induced pluripotent stem (iPS) cells

            Patient-derived pluripotent stem cells can be generated from somatic cells (skin fibroblasts, blood cells, epithelial cells, …) by introduction using Sendai virus as vectors of four genes that are expressed in ES cells. These four genes are:

            Patient derived iPSCs are useful as an unlimited source of human material:

            • studies of pathogenesis
            • development of therapies
            • drug screening
            • gene/cell therapy
            • toxicology studies

            see:

            • Noemi Fusaki, Hiroshi Ban, Akiyo Nishiyama, Koichi Saeki, and Mamoru Hasegawa, Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome, Proc Jpn Acad Ser B Phys Biol Sci v.85(8); 348-362 (2009)
            • Hiroshi Ban, Naoki Nishishita, Noemi Fusaki, Toshiaki Tabata, Koichi Saeki, Masayuki Shikamura, Nozomi Takada, Makoto Inoue, Mamoru Hasegawa, Shin Kawamata, and Shin-Ichi Nishikawa, Proc Natl Acad Sci U S A. (2011 Aug 23); 108(34): 14234–14239.

            From basic research to clinical translation

            Professor Nakauchi’s research focus was always riding basic research and clinical applications.

            From basic research to clinical translation:

            • generation of organs from iPS cells
              • next generation regenerative medicine
            • ex vivo expansion of hematopoietic stem cells
              • non-myeloablative HSC transplantation using autologous HSCs
            • novel adoptive T cell therapy using iPSC technology
            • generation of platelet from iPS cells
              • transfusion using iPSC-derived platelets
              • co-founded Megakaryon in 2011
              • going into clinical trials

            Generation of organs from iPSCs

            Interspecies organogenesis for generation of functional organs from iPSCs

            There is a lack of donor organs:

            • 116,000 men, women and children are on the US national transplant waiting list as of August 2017,
            • every 10 minutes another person is added to the waiting list for transplants
            • 33,611 transplants were performed in 2016
            • 20 people die each day waiting for a transplant
            • source:
            • illegal organ trafficking: more than 10,000 organs were sold in 2010, about 10% of transplantations performed world wide

            transplant requires life-long immunosuppression

            Issues in transplantation medicine

            • shortage of donor organs
            • immunological rejection
            • side effects and high medical cost due to lifetime immunesuppression
            • ethical issues (brain death, living donor, definition of death)

            Generation of functional organs from the patient’s own stem cell has the potential for a solution

            Future goal: generation of human organs in livestock animals

            concept:

            • iPS cells are generated from the patient
            • iPS cells are implanted in an organogenesis-disabled animal: interspecies organ complementation
            • generation of a human organ in a livestock animal
            • organ transplant from animal to patient

            Development complementation via an “organ niche” by blastocyst complementation (kidneys)

            Pluripotent stem cells from (ESCs, iPSCs) are introduced into SALL1-/- mouse blastocyst to generate organs derived from pluripotent stem cells.

            see:

            Proof of concept data were obtained in mouse-mouse chimeras for

            • pancreas (Pdx1 KO),
            • thymus (nude mouse),
            • kidney (Sall1 KO),
            • liver (Sek1 KO),
            • vessels and blood (Flk1 KO)

            Generation of interspecies chimeras: mouse <> rat

            Generation of chimeras across “Xeno-barrier”

            see:

            Interspecies organ complementation – blastocyst complementation across xenogenic barrier

            • generation of (Pdx1 KO) rat with mouse pancreas > rat with mouse PSC derived pancreas > rat-sized mouse pancreas in rat

            Transplantation of mouse islets generated in rats

            Rat pancreata can be created from rat PSCs in mice trough interspecies blastocyst complementation, however the resulting pancreata were of mouse size, creating insufficient number of islets to treat diabetes in the rat.

            To solve this issue, the reverse experiments were performed:

            Mouse PSCs were injected into Pdx-1 deficient rat blastocysts, and rat sized pancreata composed of mouse-PSC derived cells were grown. Islets prepared from these mouse-PSC derived pancreata grown in rats were then transplanted into mice with streptozotocin-induced diabetes. The transplanted islets maintained mouse-host blood glucose levels for over 370 in the absence of immunosuppression.

            These experiments show that in principle organs can be grown based on PSCs across animal barriers and used for therapy.

            Pigs and sheep have similar organ size and anatomy to human and grow to adult human size in a short time

            pigs grow to adult human size in 9 months, sheep in 10 months, but monkeys in 4 years.

            Blastocyst complementation in pigs

            • Ryo Sumazaki, Nobuyoshi Shiojiri, Shigemi Isoyama, Masayuki Masu, Kazuko Keino-Masu, Mitsujiro Osawa, Hiromitsu Nakauchi, Ryoichiro Kageyama & Akira Matsui. Conversion of biliary system to pancreatic tissue in Hes1-deficient mice. Nature Genetics, 36(1), 83 (2004)
            • Hitomi Matsunari, Hiroshi Nagashima, Masahito Watanabe, Kazuhiro Umeyama, Kazuaki Nakano, Masaki Nagaya, Toshihiro Kobayashi, Tomoyuki Yamaguchi, Ryo Sumazaki, Leonard A. Herzenberg, and Hiromitsu Nakauchi. Blastocyst complementation generates exogenic pancreas in vivo in apancreatic cloned pigs. PNAS (March 19, 2013) 110 (12) 4557-4562,
            • Hitomi Matsunari, Masahito Watanabe, Kazuaki Nakano, Shin Enosawa, Kazuhiro Umeyama, Ayuko Uchikura, Sayaka Yashima, Toru Fukuda, Nikolai Klymiuk, Mayuko Kurome, Barbara Kessler, Annegret Wuensch, Valeri Zakhartchenko, Eckhard Wolf, Yutaka Hanazono, Masaki Nagaya, Akihiro Umezawa, Hiromitsu Nakauchi, and Hiroshi Nagashima. Modeling lethal X-linked genetic disorders in pigs with ensured fertility. PNAS (January 23, 2018) 115 (4) 708-713

            Implantation of human/animal admixed embryos was prohibited by guidelines in Japan, therefore:

            Move from the University of Tokyo to Stanford University, Institute for Stem Cell Biology and Regenerative Medicine

            Achieving apancreatic sheep is the first step towards growing human iPSC derived pancreas in sheep for implantation back into humans: generation of apancreatic sheep by CRISPR/Cas9 microinjection into sheep oocytes.

            Human iPSC in mouse and sheep embryos

            The next step in the quest for developing iPCS based human organs in animals for transplant back into human patients is to investigate human iPCS in mouse and sheep.

            Human iPSC cells injected into mouse or sheep embryos normally to not migrate into the inner cell mass (ICM), however migration and proliferation can be achieved by injecting primed human iPSCs with Bcl2 expression.

            A major difficulty is caused by evolutionary divergence rats and mice diverged less than 30 million years ago, while humans and pigs or sheep diverged over 60 million years ago.

            The Japanese Government finally lifted the ban on human-animal chimera research

            Hiromitsu Nakauchi: Stem cell technology and its potential for future medicine, Ludwig Boltzmann Forum, 20 February 2020
            Hiromitsu Nakauchi: Stem cell technology and its potential for future medicine, Ludwig Boltzmann Forum, 20 February 2020
            Hiromitsu Nakauchi: Stem cell technology and its potential for future medicine, Ludwig Boltzmann Forum, 20 February 2020
            Hiromitsu Nakauchi: Stem cell technology and its potential for future medicine, Ludwig Boltzmann Forum, 20 February 2020
            Hiromitsu Nakauchi: Stem cell technology and its potential for future medicine, Ludwig Boltzmann Forum, 20 February 2020
            Hiromitsu Nakauchi: Stem cell technology and its potential for future medicine, Ludwig Boltzmann Forum, 20 February 2020
            Hiromitsu Nakauchi: Stem cell technology and its potential for future medicine, Ludwig Boltzmann Forum, 20 February 2020
            Hiromitsu Nakauchi: Stem cell technology and its potential for future medicine, Ludwig Boltzmann Forum, 20 February 2020

            contact

              Copyright (c) 2020 Eurotechnology Japan KK All Rights Reserved

            • Satoshi Nagata: NTT DOCOMO’s activity towards 5G Evolution and 6G

              Satoshi Nagata: NTT DOCOMO’s activity towards 5G Evolution and 6G

              From 5G to 6G, 12th Ludwig Boltzmann Forum, 20 February 2020

              Satoshi Nagata, NTT DOCOMO Inc., 3GPP TSG RAN Vice Chairman

              Summary by Gerhard Fasol

              Summary: Docomo towards 5G evolution and 6G

              Satoshi Nagata gave us the first ever external talk by NTT DOCOMO about 6G. DOCOMO started 5G Services in Japan on March 25, 2020, and Satoshi Nagata started to work on services beyond 5G and 6G. For an overview of DOCOMO’s 5G services and ecosystem, read DOCOMO Board Director, Executive Vice-President and CTO Hiroshi Nakamura’s talk at the 11th Ludwig Boltzmann Forum: “NTT DOCOMO driving digital transformation in the 5G era – co-create new values with partners

              5G offers three generic services: (1) enhanced mobile broadband (eMBB), (2) massive machine-type communications (mMTC), eg for IoT, (3) ultra-reliable and low-latency communications (URLLC)

              6G will include eMMB, mMTC and URLLC, and will also include new extreme requirements for special use cases, such as extremely high data rates, extreme coverage including sky, sea and space, or extremely low latency and extremely high reliability as required for autonomous vehicles, remote surgery, and massive connectivity with very high densities of sensors and actuators, and very high-precision positioning.

              We expect a fusion of cyberspace and our real world, Io type sensors in combination with AI create a cyber image of our real world, AI maybe central action which then creates action in our real world.

              Trends for 5G/6G mobile communications

              Technology evolves in 10 year phases:

              • 1G (analog) 1980-1990
                • car phones, portable telephones, shoulder phones, handy telephone
              • 2G (digital voice) 1990-2000
                • MOVA, mobile phone for everyone
              • 3G (digital voice & data) 2000-2010
                • i-Mode, information in hand, camera phones
              • 4G (smart phones) 2010-2020
                • smart phones, apps, videos, streaming
              • 5G/6G 2020-2030(?)
                • resolution of social issues, human centered value creation

              Value creation for markets evolves in 20 year phases.

              • 1980-2000 First wave
                • dissemination of mobile phones
              • 2000-2000 Second wave
                • mobile multimedia
              • 2020- Third wave
                • news business value

              5G use cases

              • Advanced mobile broadband
                • VR (virtual reality) smart glasses
                • AR (augmented reality)
                • free viewpoint image
                • high sense of presence
                • highly condensed traffic (e.g. in stadium)
                • HD image broadcast (uplink)
              • IoT: massive connectivity
                • smart city, smart home
                • smart wearable
                • smart manufacturing
              • ultra-high reliability and low latency
                • drone control
                • tactile communication
                • tele-surgery

              Observations from 5G real issues

              5G is the first generation using mm radio waves

              1G, 2G, 3G uses UHF radio bands, e.g. in the 800MHz, 2GHz ranges

              4G added low SHF bands in the 3-6 GHz ranges

              5G uses high SHF bands in the 6-30GHz and EHF bands above 30GHz

              Key technical issues are mm-wave coverage and mobility improvement, uplink performance enhancement.

              There is high interest from industry, however requirements for industrial use cases are high.

              5G first focusses on downlink speed and on a best effort basis.

              5G evolution is directed towards improving uplink speed, and to move from “best effort” basis to guaranteed performance.

              Cyber-Physical Fusion

              5G and 6G have the potential to fuse our physical world and the cyber world:

              Physical world > cyber space: create a cyber replica of the physical world

              • humans, objects, events are turned into information
              • accumulated data are turned into a cyber replica of the real world assisted by AI
              • low latency and high data transport capacity is needed

              Cyber space > physical world: cyber space actuates events in the real world

              • forecasting future events
              • data analysis turns data into value
              • actuate events in the real world
              • AI influences devices, high reliability and low latency is required

              5G supports three generic services: enhanced mobile broadband (eMBB), massive machine-type communications (mMTC) and ultra-reliable low-latency communications (URLLC)

              5G supports three generic services according to the 5G New Radio (NR) standard of the 3GPP:

              • enhanced mobile broadband (eMBB): stable connections with very high peak data rates, and lower data rates for users further away from antennas
              • massive machine-type communications (mMTC): for massive numbers of IoT devices, eg for sensing, metering and monitoring devices
              • ultra-reliable and low-latency communications (URLLC) required for self-driving cars, remote surgery and similar applications which rely on very fast response (low latency) and very high reliability and Quality of Service

              URLLC use cases include:

              • control of autonomous vehicles and traffic control
              • robot control and 3D connection with drones
              • remote surgery

              References:

              Extreme targets toward “beyond 5G” > 6G

              6G will include eMMB, mMTC and URLLC, and will include also new combinations of extreme requirements for special use cases.

              Extreme targets include

              • extremely high data rate and data capacity: peak data rates beyond 100Gbps exploiting new spectrum, 100 times capacity increase during the next 10 years
              • extreme coverage: Gbps coverage everywhere, new coverage areas, e.g. sky, sea and space
              • extremely low energy consumption, no charging and low cost: affordable mm wave/ THz and devices, devices that do not need batteries that require charging
              • extremely low latency: faster than 1 milli-second, always low latency
              • extremely high reliability: guaranteed quality of service (QoS) for a white range of use cases 7-Nines (99,99999%) reliability
              • extremely massive connectivity: massive density of connected devices, e.g. 10 million/square kilometer, sensing capabilities and high-precision positioning (e.g. centimeter precision)

              What is 6G?

              Reference:

              NTT DOCOMO White Paper on 5G Evolution and 6G, January 2020

              https://www.nttdocomo.co.jp/english/binary/pdf/corporate/technology/whitepaper_6g/DOCOMO_6G_White_PaperEN_20200124.pdf

              A variety of technical components for beyond 5G

              • new network topology
              • non-terrestrial networks
              • frequency extensions and controls
              • new radio access technologies
              • further enhanced mMIMO
              • enhanced URLLC, non public network
              • AI for everywhere in the mobile network
              • new areas driven by yet unknown use cases
              Satoshi Nagata: NTT DOCOMO’s activity towards 5G Evolution and 6G
              Satoshi Nagata: NTT DOCOMO’s activity towards 5G Evolution and 6G
              Satoshi Nagata: NTT DOCOMO’s activity towards 5G Evolution and 6G
              Satoshi Nagata: NTT DOCOMO’s activity towards 5G Evolution and 6G
              Satoshi Nagata: NTT DOCOMO’s activity towards 5G Evolution and 6G
              Satoshi Nagata: NTT DOCOMO’s activity towards 5G Evolution and 6G
              Satoshi Nagata: NTT DOCOMO’s activity towards 5G Evolution and 6G
              Satoshi Nagata: NTT DOCOMO’s activity towards 5G Evolution and 6G
              Satoshi Nagata: NTT DOCOMO’s activity towards 5G Evolution and 6G
              Satoshi Nagata: NTT DOCOMO’s activity towards 5G Evolution and 6G
              Satoshi Nagata: NTT DOCOMO’s activity towards 5G Evolution and 6G
              Satoshi Nagata: NTT DOCOMO’s activity towards 5G Evolution and 6G
              Satoshi Nagata: NTT DOCOMO’s activity towards 5G Evolution and 6G
              Satoshi Nagata: NTT DOCOMO’s activity towards 5G Evolution and 6G
              Satoshi Nagata: NTT DOCOMO’s activity towards 5G Evolution and 6G
              Satoshi Nagata: NTT DOCOMO’s activity towards 5G Evolution and 6G

              contact

                Copyright (c) 2020 Eurotechnology Japan KK All Rights Reserved